While initial CD13 promoter studies were performed with chloramphenicol acetyl transferase (CAT) assays and Northern blots (Shapiro et al, 1991), we made use of RT–PCR and promoter-luciferase assays allowing us to detect the activities of both promoters in 1F6 melanoma cells and clones. The gene discussed is ANPEP; the disease is melanoma.